Dose-dependent metabolite changes after ethanol intoxication in rat prefrontal cortex using in vivo magnetic resonance spectroscopy.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
23 07 2019
Historique:
received: 21 08 2018
accepted: 10 07 2019
entrez: 25 7 2019
pubmed: 25 7 2019
medline: 24 10 2020
Statut: epublish

Résumé

Ethanol disrupts the balance between the excitatory (glutamatergic) and inhibitory (GABAergic) neurotransmission systems. We aimed to assess how acute ethanol intoxication in rats affects the levels of GABA, glutamate and other cerebral metabolites after injection of two different doses of ethanol. One in vivo magnetic resonance spectrum of the prefrontal cortex region was acquired before and six spectra were acquired after intraperitoneal injections of saline or ethanol (1 g/kg or 2 g/kg). Brain kinetics after exposure to ethanol were compared to blood ethanol kinetics. GABA levels significantly decreased after injection of 1 g/kg but not 2 g/kg doses of ethanol. Choline levels, which serve as a marker of alterations in membrane composition, significantly decreased after injection of 2 g/kg but not 1 g/kg doses of ethanol. Acute ethanol intoxication appears to result in specific dose-dependent changes in the GABA level and choline level.

Identifiants

pubmed: 31337845
doi: 10.1038/s41598-019-47187-4
pii: 10.1038/s41598-019-47187-4
pmc: PMC6650461
doi:

Substances chimiques

Glutamine 0RH81L854J
Ethanol 3K9958V90M
Glutamic Acid 3KX376GY7L
gamma-Aminobutyric Acid 56-12-2
Creatine MU72812GK0
Choline N91BDP6H0X

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

10682

Références

Neuroscience. 2014 Mar 14;262:107-17
pubmed: 24406441
Neuropsychopharmacology. 2013 May;38(6):1121-9
pubmed: 23306181
J Neurochem. 2014 Mar;128(5):628-40
pubmed: 24164397
Int J Mol Sci. 2017 Aug 21;18(8):
pubmed: 28825683
Neuropsychopharmacology. 2006 Dec;31(12):2683-91
pubmed: 16407891
AJNR Am J Neuroradiol. 2013 Feb;34(2):259-65
pubmed: 22268095
J Cereb Blood Flow Metab. 2009 May;29(5):891-902
pubmed: 19240741
Neuroscience. 2008 Apr 22;153(1):259-67
pubmed: 18358631
Addict Biol. 2016 Nov;21(6):1199-1216
pubmed: 26283309
Biol Psychiatry. 2010 May 1;67(9):846-54
pubmed: 20044076
Neuroimage. 2014 Feb 1;86:43-52
pubmed: 23246994
MAGMA. 2001 May;12(2-3):141-52
pubmed: 11390270
NMR Biomed. 2000 May;13(3):129-53
pubmed: 10861994
J Chromatogr. 1987 Feb 20;414(1):248-50
pubmed: 3571391
Nat Rev Neurosci. 2011 Jun 02;12(7):400-13
pubmed: 21633380
J Physiol Paris. 2013 Dec;107(6):471-82
pubmed: 23684970
Alcohol Clin Exp Res. 2014 Apr;38(4):969-79
pubmed: 24512596
Eur J Pharmacol. 1985 May 20;111(3):365-8
pubmed: 2990958
Prog Nucl Magn Reson Spectrosc. 2012 Jan;60:29-41
pubmed: 22293397
Biomed Res Int. 2014;2014:351903
pubmed: 24783201
J Magn Reson. 1997 Nov;129(1):35-43
pubmed: 9405214
Magn Reson Med. 1999 Apr;41(4):649-56
pubmed: 10332839
J Chromatogr B Biomed Sci Appl. 1997 Dec 19;704(1-2):365-8
pubmed: 9518172
Biol Psychiatry. 2012 Feb 1;71(3):239-46
pubmed: 21855054

Auteurs

Louise Carton (L)

University Lille, Inserm U1171 'Degenerative and vascular cognitive disorders', F-59000, Lille, France. louise.carton@univ-lille.fr.
CHU Lille, department of Pharmacology, F-59000, Lille, France. louise.carton@univ-lille.fr.
CHU Lille, Psychiatry and Addiction Medicine Department, F-59000, Lille, France. louise.carton@univ-lille.fr.

Florent Auger (F)

University Lille, Inserm U1171 'Degenerative and vascular cognitive disorders', F-59000, Lille, France.
University Lille, Preclinical Imaging Core Facility, F-59000 Lille, France.

Maeva Kyheng (M)

Univ. Lille, EA 2694 - Santé publique : épidémiologie et qualité des soins, F-59000 Lille, France.
CHU Lille, Service de Biostatistiques, F-59000 Lille, France.

Maud Pétrault (M)

University Lille, Inserm U1171 'Degenerative and vascular cognitive disorders', F-59000, Lille, France.
CHU Lille, department of Pharmacology, F-59000, Lille, France.

Nicolas Durieux (N)

University Lille, Preclinical Imaging Core Facility, F-59000 Lille, France.

Delphine Allorge (D)

CHU Lille, Unité Fonctionnelle de Toxicologie, F-59000, Lille, France.
University Lille, EA 4483 - IMPECS - IMPact de l'Environnement Chimique sur la Santé humaine, F-59000, Lille, France.

Olivier Cottencin (O)

CHU Lille, Psychiatry and Addiction Medicine Department, F-59000, Lille, France.
University Lille, CNRS UMR 9193 SCALab PsyCHIC Team, F-59000, Lille, France.

Renaud Jardri (R)

University Lille, CNRS UMR 9193 SCALab PsyCHIC Team, F-59000, Lille, France.
CHU Lille, Psychiatry Department, CURE platform, Fontan Hospital, F-59000, Lille, France.

Régis Bordet (R)

University Lille, Inserm U1171 'Degenerative and vascular cognitive disorders', F-59000, Lille, France.
CHU Lille, department of Pharmacology, F-59000, Lille, France.

Benjamin Rolland (B)

Service Universitaire d'Addictologie de Lyon (SUAL), Pôle MOPHA, CRNL, Inserm U1028, CNRS UMR5292, Université Lyon 1, Centre Hospitalier Le Vinatier, Bron, France.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH